Hastings Gregory S, an officer at Neogen Corp, has filed a report detailing a change in his ownership of the company's stock. This filing is significant as it reflects the ongoing dynamics within the company and the broader industry.
Background
Neogen Corp, identified by the Central Index Key 0000711377, operates within the in vitro and in vivo diagnostic substances sector. The company is incorporated in Michigan and has its fiscal year ending on May 31. Hastings Gregory S serves as the Vice President of Animal Health at Neogen, a role that places him in a key position to influence the company's strategic direction.
What the Filing Says
According to the recent filing dated October 23, 2026, Hastings reported that he holds 32,368 shares of Neogen Corp's common stock. The filing states, "no securities owned" were reported prior to this transaction, indicating a change in his ownership status.
Impact
This update may affect corporate governance at Neogen, as Hastings' position as an officer and his ownership stake could play a role in decision-making processes. Stakeholders and investors may pay close attention to such changes, as they can signal shifts in corporate strategy or priorities.
What's Next
The filing does not say what happens next.